POsitioning for Esophageal Cancer Resection (POETRI)
POsitioning for Esophageal Cancer Resection - a Randomized Controlled TRIal (POETRI)
Open thoracoabdominal esophagectomy (TAE) is the standard curative treatment modality for resectable esophageal cancer. TAE can be achieved by positioning the patient in the supine position for the abdominal part and in a left-lateral decubitus (LLD) position for the thoracic part, or by performing both parts in a left-screwed supine position (LSS). Aim of the present study is to compare peri- and postoperative outcome variables after TAE for esophageal cancer in the two positions.
POETRI is designed as a single-center, randomized controlled trial with two parallel arms including patients with resectable esophageal cancer and type I cancers of the esophagogastric junction (AEG I). Exclusion criteria are inability to tolerate surgery or both types of positioning, inability to perform an intrathoracic anastomosis, non-malignant pathologies. The primary endpoint is operating time. Secondary endpoints are morbidity, lymph node yield, pulmonary function, pain control and wound healing assessed during a follow-up of 3 months.
POETRI is a single-center, randomized controlled trial to evaluate different positioning and thoracic access during radical open thoracoabdominal esophagectomy for patients with resectable esophageal cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dresden, Germany, 01307
- Department of Surgery, University Hospital Dresden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Newly diagnosed, non-metastatic esophagus cancer (squamous or adenocarcinoma) or AEG I tumors requiring curative thoracoabdominal esophagectomy with intrathoracic anastomosis of a gastric tube immediately after diagnosis or after neoadjuvant treatment
- Patients are considered fit for surgery by a local interdisciplinary team of surgeons, medical oncologists and anesthesiologists (ECOG performance status of 0,1, or 2).
- Age ≥ 18 years
- Written informed consent
Exclusion Criteria:
- Preoperative established indication for colon interposition or cervical anastomosis
- Preoperative diagnosed tracheo-esophageal fistula
- History of right thoracotomy or prior lung surgery
- Physical inability of the described intraoperative patient positioning
- Non-malignant esophageal pathology or other malignancies except squamous or adenocarcinoma
- Planned laparoscopic or thoracoscopic surgical approach
- Patients not eligible for TAE (ASA ≥ 4)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Repositioning Group
The patient is placed on a vacuum mattress in supine position for the abdominal part using a midline laparotomy.
After completion of the abdominal part, the abdomen is closed and dressed in standard fashion and the patient is repositioned under full anesthesia is a left-lateral decubitus (LLD) position.
After the thorax is sterile prepped and draped, a right dorso-lateral thoracotomy in the 4th to 6th intercostal space under preservation of body of the serratus muscle is performed.
|
|
|
Experimental: Single positioning
The patient is placed on a vacuum mattress and in a left-screwed supine position for the entire operative procedure.
The pelvis and the lower extremities are placed at 0° rotation, whereas the torso is rotated leftwards to an angle of 45° (Fig. 1).
The patient is prepped and draped from the shoulders to the inguinal region.
A midline laparotomy is done for the abdominal part and the abdomen closed afterwards.
For the thoracic part, the operating table is tilted about 30° to the left, and a right anterolateral thoracotomy is performed in the 4th to 6th intercostal space.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
operating time
Time Frame: The endpoint is assessed at the end of the operation (finishing of all wound dressings) on the day of operation.
|
Operating time is defined from the start of patient positioning until final closing and dressing of all wounds.
|
The endpoint is assessed at the end of the operation (finishing of all wound dressings) on the day of operation.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Thilo Welsch, MD, Department of Surgery, University Hospital Dresden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TW-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.